Image credit: prnewswire
AIRS Medical, a healthcare startup based in South Korea, has raised approximately $20M in Series B funding. The round of Series B funding welcomed new investors Q Capital Partners and Hanwha Life and additional funds from Klim Ventures, which had contributed to the startup's Series A funding.
Co-founded by graduates of Seoul National University in October 2018, AIRS Medical is a startup that uses digitalized, artificial intelligence (AI)-based diagnostic tests and robotics technologies to provide a better clinical experience for both patients and healthcare providers.
The has startup successfully developed and commercialized its technology, called SwiftMR, and has been using it to benefit the broader healthcare community. SwiftMR is an AI-powered MRI reconstruction software that enhances MR images acquired under various conditions, contributing to a higher level of data accuracy and a better patient experience.
Following the successful implementation of the software's business model in the domestic market and with the support of Born2Global and the KOSME-MATTER US Market Adoption Programme, AIRS Medical is now introducing its software in other parts of the world including the United States, Europe, Southeast Asia, and South America.
Hye-seong Lee, CEO of AIRS Medical said, "Through the Series B funding we've secured, we will be taking our innovative diagnostic solutions to the global market."
